Pediatric acute myeloid leukemia (AML) is a heterogeneous disease, characterized by
different collaborating karyotypic and molecular abnormalities, which are used in risk group …

Translocation (10; 17)(p15; q21) is a recurrent abnormality that has been reported in only
seven cases of acute leukemia, including two by our group [1](available at: http://cgap. nci …

The t (10; 17)(p15; q21) translocation is a very rare but recurrent cytogenetic aberration in
acute myeloid leukemia (AML), which would be classified as AML, not otherwise specified …

Abstract Recurring chromosomal translocation t (10; 17)(p15; q21) present in a subset of
human acute myeloid leukemia (AML) patients creates an aberrant fusion gene termed …

The acute myeloid leukemia (AML) subtype M4Eo occurs in 5% of all AML cases and is
usually associated with either an inv (16)(p13. 1q22) or at (16; 16)(p13. 1; q22) …

The reciprocal chromosomal rearrangement t (8; 16)(p11; p13) is rare both in adult and
pediatric acute myeloid leukemias (AML) accounting 0.2–0.4% of de novo AML and 6.5% of …

Acute myeloid leukemia (AML) with translocation t (8; 16)(p11; p13) is an infrequent
leukemia subtype with characteristic clinicobiological features. This translocation leads to …

UBTF tandem duplications (UBTF-TDs) have recently emerged as a recurrent alteration in
pediatric and adult acute myeloid leukemia (AML). UBTF-TD leukemias are characterized by …

Abstract The t (8; 16)(p11; p13) is a rare translocation involved in de novo and therapy-
related myelomonocytic and monocytic acute leukemia. It fuses two genes encoding histone …

Abstract The translocation t (8; 16)(p11; p13) is associated with acute myeloid leukemia
displaying monocytic differentiation (AML FAB M4/5) and fuses the MOZ (also named …